Citigroup Inc Talis Biomedical Corp Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.81 - $1.44 $2,964 - $5,270	-3,660 Reduced 96.47%	134 $0
Q1 2022 May 12, 2022	BUY	$1.3 - $4.19 $149 - $481	115 Added 3.13%	3,794 $5,000
Q4 2021 Feb 10, 2022	BUY	$3.81 - $6.17 $7,185 - $11,636	1,886 Added 105.19%	3,679 $15,000
Q3 2021 Nov 10, 2021	BUY	$6.02 - $12.46 $10,793 - $22,340	1,793 New	1,793 $11,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.6M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.